Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53

Novonesis arose from a 2023 merger of Novozymes and Chr Hansen, and is a highly profitable powerhouse. CSO Claus talks about the applications of Novonesis’ technology, its low profile among consumers, and how hard it is for biosolutions startups to scale up. ⭐️ ABOUT THE SPEAKER Claus first joined Novozymes in 1993 and led its R&D both in Denmark and the US, with six years as CSO. He has a Master’s degree in biochemistry and an MBA. 🔗 LINKS MENTIONED Novonesis’ website — https://www.novonesis.com/en Merger of Novozymes and Chr Hansen — https://www.novonesis.com/en/news/novozymes-and-chr-hansen-announce-name-future-combined-company-novonesis Novonesis’ nine-month results in 2025 — https://backend.novonesis.com/sites/default/files/document/2025-11/2025_46_9M_Interim_report.pdf Novonesis and Benchling partnership in 2024 — https://www.benchling.com/news/novonesis-and-benchling-long-term-partnership-to-power-rd EU biosolutions — https://research-and-innovation.ec.europa.eu/research-area/environment/bioeconomy/bio-based-products-and-processes_en 📜 TRANSCRIPT Read the full transcript here: https://flot.bio/episode/claus-crone-fuglsang-novonesis-biosolutions/ 📖 SHORT BLOGS BASED ON THIS EPISODE: How AI, AlphaFold and Digital Twins are Transforming Biosolutions: https://flot.bio/ai-biosolutions-claus-crone-fuglsang/ 💸 DONATE We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme ⭐️ SPONSORSHIP Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts! 🫶 FOLLOW US Newsletter: http://eepurl.com/h_fnmH LinkedIn: https://www.linkedin.com/company/flot-bio/ X (Twitter): https://x.com/FlotBio 🙏 LIKE/FOLLOW/REVIEW Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below. 🎙️ABOUT FLOT.BIO Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free. ⏰ TIMESTAMPS [00:00:00] Intro [00:02:19] Novonesis: the Novozymes and Chr Hansen merger [00:09:51] Under the consumer radar [00:12:52] Business divisions and myriad applications [00:20:46] The scaling challenge in biosolutions [00:27:39] Novonesis’ profitability and growth [00:36:34] Genetic engineering and cool patents [00:47:57] Novonesis’ growing AI use [00:56:34] Claus Crone Fuglsang’s enthusiasm for his work [01:00:09] Industrial biotech globally [01:04:15] Quick-fire questions